New evidence challenges the effectiveness of the Galleri test, a blood test claimed to detect over 50 types of cancer early. The article raises concerns about the test’s accuracy and ethical implications, particularly in the context of its ongoing trial by the NHS. This development could significantly impact the future of early cancer detection technologies and their adoption in clinical practice.
New Evidence Casts Doubt on Galleri Test for Early Cancer Detection (CLP)
0